[
  {
    "ts": "2025-11-13T09:40:00+00:00",
    "headline": "2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors",
    "summary": "Healthcare stocks have plenty to offer new investors.",
    "url": "https://www.fool.com/investing/2025/11/13/quality-healthcare-stock-begin-investor-lly-hims/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "a402df7b-bac8-37a9-b9fa-36e1f8d41669",
      "content": {
        "id": "a402df7b-bac8-37a9-b9fa-36e1f8d41669",
        "contentType": "STORY",
        "title": "2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors",
        "description": "",
        "summary": "Healthcare stocks have plenty to offer new investors.",
        "pubDate": "2025-11-13T09:40:00Z",
        "displayTime": "2025-11-13T09:40:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/f1e5799fa47b671ae4f816ab2e4b51fa",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "investor looking at laptop in kitchen",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bZKQ2Ghc1HxR4DsmVqlAEQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/f1e5799fa47b671ae4f816ab2e4b51fa.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vms4uS1AtguTlqeMXnZuWA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/f1e5799fa47b671ae4f816ab2e4b51fa.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/13/quality-healthcare-stock-begin-investor-lly-hims/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-quality-healthcare-stocks-could-094000924.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "HIMS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T09:25:00+00:00",
    "headline": "1 Incredible Reason to Buy LLY's Stock in November",
    "summary": "Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher.",
    "url": "https://www.fool.com/investing/2025/11/13/incredible-reason-buy-lilly-stock-november-lly/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "07eea724-4a25-3d2c-b187-fd8159a3be97",
      "content": {
        "id": "07eea724-4a25-3d2c-b187-fd8159a3be97",
        "contentType": "STORY",
        "title": "1 Incredible Reason to Buy LLY's Stock in November",
        "description": "",
        "summary": "Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher.",
        "pubDate": "2025-11-13T09:25:00Z",
        "displayTime": "2025-11-13T09:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/b220831fe87639871d1ecc45cb04b2b0",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A basket of prescription drugs, with a lengthy cash-register receipt.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ieOEbvgFsUoqv8CzTFRZiA--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/b220831fe87639871d1ecc45cb04b2b0.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3LLUaSFfXLdxbFHAM1z8bg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/b220831fe87639871d1ecc45cb04b2b0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/13/incredible-reason-buy-lilly-stock-november-lly/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/1-incredible-reason-buy-llys-092500558.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T10:15:00+00:00",
    "headline": "Here Are the Top Growth Healthcare Stocks Every New Investor Should Know",
    "summary": "These top growth stocks have plenty of room left to run.",
    "url": "https://www.fool.com/investing/2025/11/13/here-are-the-top-growth-healthcare-stocks-every-ne/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "693ca2d1-1d15-3d83-b4b1-ec67bd4f8838",
      "content": {
        "id": "693ca2d1-1d15-3d83-b4b1-ec67bd4f8838",
        "contentType": "STORY",
        "title": "Here Are the Top Growth Healthcare Stocks Every New Investor Should Know",
        "description": "",
        "summary": "These top growth stocks have plenty of room left to run.",
        "pubDate": "2025-11-13T10:15:00Z",
        "displayTime": "2025-11-13T10:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/1eeae39d8bc965c581350ddc1fb9afab",
          "originalWidth": 1400,
          "originalHeight": 978,
          "caption": "professional thoughtful investor ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0zgFcCdo1wBatd4Z_KJgfg--~B/aD05Nzg7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/1eeae39d8bc965c581350ddc1fb9afab.cf.webp",
              "width": 1400,
              "height": 978,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FJAvhMuIQ0.26A5wB2Z4XQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/1eeae39d8bc965c581350ddc1fb9afab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/13/here-are-the-top-growth-healthcare-stocks-every-ne/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-growth-healthcare-stocks-every-101500662.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T12:26:37+00:00",
    "headline": "LLY: Eli Lilly Stock Climbs After Exiting CVS Drug Plan",
    "summary": "Eli Lilly Dumps CVS Health Plan After Coverage Rift on Weight-Loss Drugs",
    "url": "https://finance.yahoo.com/news/lly-eli-lilly-stock-climbs-122637963.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "ab2befa7-1b0c-3e69-89d4-e85400d19b75",
      "content": {
        "id": "ab2befa7-1b0c-3e69-89d4-e85400d19b75",
        "contentType": "STORY",
        "title": "LLY: Eli Lilly Stock Climbs After Exiting CVS Drug Plan",
        "description": "",
        "summary": "Eli Lilly Dumps CVS Health Plan After Coverage Rift on Weight-Loss Drugs",
        "pubDate": "2025-11-13T12:26:37Z",
        "displayTime": "2025-11-13T12:26:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8b14zxH4BANQFraIfqB7ug--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j_oIKXponyFLhltsjvcwTQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lly-eli-lilly-stock-climbs-122637963.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lly-eli-lilly-stock-climbs-122637963.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T12:00:00+00:00",
    "headline": "Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management",
    "summary": "Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (\"Mangoceuticals\" or the \"Company\"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, and a pioneer in innovative wellness solutions, is excited to announce that it has launched MangoRx Direct and PeachesRx Direct, two integrated programs that provide direct access to authentic Zepbound® (t",
    "url": "https://finance.yahoo.com/news/mangoceuticals-partners-eli-lilly-novo-120000605.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "6952f4e0-d171-3970-9b60-067492c99b05",
      "content": {
        "id": "6952f4e0-d171-3970-9b60-067492c99b05",
        "contentType": "STORY",
        "title": "Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management",
        "description": "",
        "summary": "Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (\"Mangoceuticals\" or the \"Company\"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, and a pioneer in innovative wellness solutions, is excited to announce that it has launched MangoRx Direct and PeachesRx Direct, two integrated programs that provide direct access to authentic Zepbound® (t",
        "pubDate": "2025-11-13T12:00:00Z",
        "displayTime": "2025-11-13T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/94775c7523023e222b2a19fc37cc02ca",
          "originalWidth": 8000,
          "originalHeight": 4500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XnuNJ9Qe6ko.i5UiATBWRA--~B/aD00NTAwO3c9ODAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/94775c7523023e222b2a19fc37cc02ca.cf.webp",
              "width": 8000,
              "height": 4500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Yet6sa3uxTjLL1d634T49w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/94775c7523023e222b2a19fc37cc02ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mangoceuticals-partners-eli-lilly-novo-120000605.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mangoceuticals-partners-eli-lilly-novo-120000605.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MGRX"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T13:00:00+00:00",
    "headline": "MeiraGTx Reports Third Quarter 2025 Financial and Operational Results",
    "summary": "Entered into broad strategic collaboration with Eli Lilly and Company (“Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment of one of the most severe inherited retinopathies, Leber congenital amaurosis 4 (LCA4) Released material under the Company’s Specials license for a second rare pediatric ophthalmology condition caused by mutations in BBS10, with the prescribing physician treating the first patient during the quarte",
    "url": "https://finance.yahoo.com/news/meiragtx-reports-third-quarter-2025-130000204.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "812c53ea-de5a-309c-897d-e44cb77c046d",
      "content": {
        "id": "812c53ea-de5a-309c-897d-e44cb77c046d",
        "contentType": "STORY",
        "title": "MeiraGTx Reports Third Quarter 2025 Financial and Operational Results",
        "description": "",
        "summary": "Entered into broad strategic collaboration with Eli Lilly and Company (“Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment of one of the most severe inherited retinopathies, Leber congenital amaurosis 4 (LCA4) Released material under the Company’s Specials license for a second rare pediatric ophthalmology condition caused by mutations in BBS10, with the prescribing physician treating the first patient during the quarte",
        "pubDate": "2025-11-13T13:00:00Z",
        "displayTime": "2025-11-13T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/7d3a2fa2ab3c203b44f402dd7f69c584",
          "originalWidth": 404,
          "originalHeight": 80,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LLrv0pWs64Owa1k4_MUk_Q--~B/aD04MDt3PTQwNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7d3a2fa2ab3c203b44f402dd7f69c584.cf.webp",
              "width": 404,
              "height": 80,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zCWlLjc7lkVTrKj0pb0egA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7d3a2fa2ab3c203b44f402dd7f69c584.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/meiragtx-reports-third-quarter-2025-130000204.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/meiragtx-reports-third-quarter-2025-130000204.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MGTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T13:07:00+00:00",
    "headline": "Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month",
    "summary": "As National Alzheimer's Awareness Month spotlights new treatments, healthcare ETFs like XLV and VHT might gain fresh investor appeal.",
    "url": "https://finance.yahoo.com/news/shine-light-healthcare-etfs-amid-130700763.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "1efc532f-b50e-31ff-8c47-35005ea467a2",
      "content": {
        "id": "1efc532f-b50e-31ff-8c47-35005ea467a2",
        "contentType": "STORY",
        "title": "Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month",
        "description": "",
        "summary": "As National Alzheimer's Awareness Month spotlights new treatments, healthcare ETFs like XLV and VHT might gain fresh investor appeal.",
        "pubDate": "2025-11-13T13:07:00Z",
        "displayTime": "2025-11-13T13:07:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/08205d0828719b0f187e3bc35c1e2718",
          "originalWidth": 620,
          "originalHeight": 438,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C4sxFiG08TiZ3eQTIwZmAg--~B/aD00Mzg7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08205d0828719b0f187e3bc35c1e2718.cf.webp",
              "width": 620,
              "height": 438,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZdidrD47NJkM00idB6nMCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08205d0828719b0f187e3bc35c1e2718.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/shine-light-healthcare-etfs-amid-130700763.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/shine-light-healthcare-etfs-amid-130700763.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "VHCIX"
            },
            {
              "symbol": "VHT"
            },
            {
              "symbol": "IBRN"
            },
            {
              "symbol": "FTXH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T14:45:38+00:00",
    "headline": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
    "summary": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
    "url": "https://finance.yahoo.com/news/nike-upgraded-dollar-tree-downgraded-144538422.html",
    "source": "The Fly",
    "provider": "yfinance",
    "raw": {
      "id": "8797ed93-cd75-34fe-b872-cf042d802372",
      "content": {
        "id": "8797ed93-cd75-34fe-b872-cf042d802372",
        "contentType": "STORY",
        "title": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
        "description": "",
        "summary": "Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls",
        "pubDate": "2025-11-13T14:45:38Z",
        "displayTime": "2025-11-13T14:45:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec",
          "originalWidth": 1200,
          "originalHeight": 628,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YHTvjvqtNAYBPYViMXYCow--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 1200,
              "height": 628,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J3gfZRz3Jb2im4_aLYVn4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Fly",
          "url": "https://thefly.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nike-upgraded-dollar-tree-downgraded-144538422.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nike-upgraded-dollar-tree-downgraded-144538422.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DASH"
            },
            {
              "symbol": "SSTI"
            },
            {
              "symbol": "CRCL"
            },
            {
              "symbol": "NKE"
            },
            {
              "symbol": "KRRO"
            },
            {
              "symbol": "DLTR"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "COO"
            },
            {
              "symbol": "BKNG"
            },
            {
              "symbol": "AZO"
            },
            {
              "symbol": "LWAY"
            },
            {
              "symbol": "FAST"
            },
            {
              "symbol": "VITL"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "RKT"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T04:36:00+00:00",
    "headline": "1 Unpopular Stock That Deserves a Second Chance and 2 We Question",
    "summary": "Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.",
    "url": "https://finance.yahoo.com/news/1-unpopular-stock-deserves-second-043600548.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "feff2771-0d34-3ba6-9515-200308435bdb",
      "content": {
        "id": "feff2771-0d34-3ba6-9515-200308435bdb",
        "contentType": "STORY",
        "title": "1 Unpopular Stock That Deserves a Second Chance and 2 We Question",
        "description": "",
        "summary": "Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.",
        "pubDate": "2025-11-13T04:36:00Z",
        "displayTime": "2025-11-13T04:36:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/af71771f38b9c34b67289421c228be11",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "THR Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SLIUgw0he7xoG4BEchhlPg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/af71771f38b9c34b67289421c228be11.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wqCBfbBb4GybYAhY3hNBlw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/af71771f38b9c34b67289421c228be11.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/1-unpopular-stock-deserves-second-043600548.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/1-unpopular-stock-deserves-second-043600548.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "CATY"
            },
            {
              "symbol": "THR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T15:54:00+00:00",
    "headline": "Hypoglycemia Market Report 2025: Pipeline Holds 16 Molecules, with No Assets in the Pre-registration Stage, Three Assets in Phase III Development, and Another Four in Phase II",
    "summary": "Key market opportunities in hypoglycemia therapeutics include leveraging the high incidence in India for market expansion and innovation, targeting the three Phase III pipeline assets for accelerated development, and capitalizing on recent strategic alliances and M&A activities to enhance competitive positioning.Dublin, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The \"Hypoglycemia: Market View\" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven overview of the c",
    "url": "https://finance.yahoo.com/news/hypoglycemia-market-report-2025-pipeline-155400748.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "a5e1975e-bf76-3868-8812-6477e734d563",
      "content": {
        "id": "a5e1975e-bf76-3868-8812-6477e734d563",
        "contentType": "STORY",
        "title": "Hypoglycemia Market Report 2025: Pipeline Holds 16 Molecules, with No Assets in the Pre-registration Stage, Three Assets in Phase III Development, and Another Four in Phase II",
        "description": "",
        "summary": "Key market opportunities in hypoglycemia therapeutics include leveraging the high incidence in India for market expansion and innovation, targeting the three Phase III pipeline assets for accelerated development, and capitalizing on recent strategic alliances and M&A activities to enhance competitive positioning.Dublin, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The \"Hypoglycemia: Market View\" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven overview of the c",
        "pubDate": "2025-11-13T15:54:00Z",
        "displayTime": "2025-11-13T15:54:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hypoglycemia-market-report-2025-pipeline-155400748.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hypoglycemia-market-report-2025-pipeline-155400748.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]